These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10460311)

  • 21. Influence of response topography on the effect of apomorphine and amphetamine on operant behavior of pigeons.
    Graeff FG; De Oliveira L
    Psychopharmacologia; 1975; 41(2):127-32. PubMed ID: 1171486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine.
    Alloway KD; Rebec GV
    Neuropharmacology; 1984 Sep; 23(9):1033-9. PubMed ID: 6096755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus effects of a low dose of apomorphine in the rat.
    Tang AH; Franklin SR
    Psychopharmacology (Berl); 1987; 91(1):61-6. PubMed ID: 3103160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different dopaminergic mechanisms for amfonelic acid, amphetamine and apomorphine.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Oct; 13(4):497-500. PubMed ID: 7433481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine.
    Fink JS; Smith GP
    Brain Res; 1980 Nov; 201(1):107-27. PubMed ID: 7191345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
    Schwabe K; Koch M
    Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine, apomorphine and investigatory behavior in the rat: analysis of the structure and pattern of responses.
    Kelley AE; Winnock M; Stinus L
    Psychopharmacology (Berl); 1986; 88(1):66-74. PubMed ID: 3080777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.
    Widzowski DV; Cory-Slechta DA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):526-34. PubMed ID: 8355188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
    Hooks MS; Jones DN; Holtzman SG; Juncos JL; Kalivas PW; Justice JB
    Psychopharmacology (Berl); 1994 Oct; 116(2):217-25. PubMed ID: 7862951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
    Khroyan TV; Fuchs RA; Beck AM; Groff RS; Neisewander JL
    Psychopharmacology (Berl); 1999 Mar; 142(4):383-92. PubMed ID: 10229063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dopamine agents on schedule- and deprivation-induced drinking in rats.
    Snodgrass SH; Allen JD
    Pharmacol Biochem Behav; 1987 Jul; 27(3):463-75. PubMed ID: 3659069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.